Alfa Cytology employs the latest research technology.


Scientific Excellence

Customized Solutions

Collaborative Approach

Confidentiality and Data Security

Most Common Cancers

Explore our solutions to gain a deeper understanding of specific diseases and drive advancements in cancer resarch.

Targets and Pathways

From immune checkpoint inhibitors to growth inhibitors and metabolic modulators, we are dedicated to advancing the field of cancer therapy.

Immune Checkpoint Inhibitors picture

Immune Checkpoint Inhibitors

We specialize in developing therapies that target immune checkpoints, such as PD-1, PD-L1, and CTLA-4, to enhance the body's immune response to cancer cells.

Cancer Growth Inhibitors picture

Cancer Growth Inhibitors

Our services focus on the development of growth inhibitors to disrupt cancer cell growth pathways, e.g., CDK, VEGF-VEGFR, PI3K/AKT/mTOR pathway, PARP, and disrupt tumor cell survival.

Cytokine and Chemokine Pathway Inhibitors picture

Cytokine and Chemokine Pathway Inhibitors

Our company is dedicated to the development of cytokine and chemokine pathway inhibitors that inhibit angiogenesis and interfere with tumor cell metabolism, e.g., inhibition of TNF-α, IL-1, IL-6, chemokine receptors, etc.

Protein Kinase Inhibitors picture

Protein Kinase Inhibitors

We offer expertise in developing inhibitors that target specific protein kinases implicated in cancer, e.g., EGFR, HER2, ALK .

Cancer Stem Cells Inhibitors picture

Cancer Stem Cells Inhibitors

Our company focuses on the development of tumor stem cell inhibitors, with a particular focus on key signaling pathway inhibitors such as Notch and Wnt.

TAM Modulators picture

TAM Modulators

Our company is deeply engaged in the research field of TAM modulator, especially in the three key targets of AXL, MER and TYRO3.

NK Modulators picture

NK Modulators

In our company's scientific research, the study of NK modulators has been at the core of our research, especially on a series of key targets such as NKG2D, NKp30, NKp44, NKp46, NKG2A, and KIR.

IAP Inhibitors picture

IAP Inhibitors

IAP Inhibitors research has always been at the core of our company's research, and we have focused on the in-depth study of key targets such as XIAP, cIAP1, and the NF-κB pathway.

Autophagy Inhibitors picture

Autophagy Inhibitors

In the field of autophagy modulator research, our company has a deep professional background and unique technical advantages, with a special focus on key targets such as VPS34, ATG, mTOR and Beclin 1.

Multiple Molecule Types

From small molecule drugs and therapeutic antibodies to cell-based therapies and gene therapies, we offer comprehensive support for the development of innovative treatments.

Our Innovative Services

We offer a range of specialized services tailored to each phase, enabling comprehensive exploration and advancement in the field of oncology.

Our Innovative Services

Get in Touch

Send us a message, we will respond soon.

Contact Details